Stock Price
66.88
Daily Change
-4.78%
Yearly
-25.80%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Daiichi Sankyo 2,602.00 -4.00 -0.15% -26.31%
Acadia Pharmaceuticals 21.53 -0.36 -1.64% -56.54%
Agios Pharmaceuticals 29.23 -1.78 -5.74% -35.67%
Alnylam Pharmaceuticals 127.18 -2.94 -2.26% -17.81%
Alexion Pharmaceuticals 182.50 0 0% 70.54%
Amgen 224.00 1.54 0.69% -9.59%
Arena Pharmaceuticals 89.79 0.16 0.18% 15.86%
Avrobio Inc 1.84 -0.07 -3.66% -87.26%
BioCryst Pharmaceuticals 14.12 -0.88 -5.87% 62.11%
Biogen 218.94 -0.40 -0.18% -18.27%
Bluebird Bio 7.30 -0.42 -5.44% -83.78%
BioMarin Pharmaceutical 83.05 -0.65 -0.78% -0.12%
Capricor Therapeutics 2.95 -0.25 -7.81% -53.76%
Esperion Therapeutics 3.65 -0.27 -6.89% -88.64%
Gilead Sciences 67.27 -0.10 -0.15% 4.00%
GW Pharmaceuticals 218.96 0 0% 108.53%
Intercept Pharmaceuticals 14.44 -0.75 -4.84% -60.77%
Incyte Corp 72.26 -1.26 -1.71% -20.83%
Insmed 20.42 -0.89 -4.15% -45.50%
Ionis Pharmaceuticals 30.14 -1.04 -3.31% -50.34%
Eli Lilly 236.70 -1.13 -0.48% 12.65%
Moderna Inc 150.03 -4.93 -3.18% -5.97%
Mirati Therapeutics 107.83 -5.15 -4.56% -47.11%
Neurocrine Biosciences 72.45 -3.06 -4.05% -35.27%
Nektar Therapeutics 10.36 -0.29 -2.72% -43.82%
Lumos Pharma Inc. 9.09 1.10 13.77% -48.06%
Novavax 72.92 -6.41 -8.10% -45.59%
Pfizer 53.37 0.35 0.66% 48.83%
PTC Therapeutics 38.52 -1.02 -2.56% -31.67%
Ultragenyx Pharmaceutical 64.33 -3.65 -5.36% -54.25%
Regeneron Pharmaceuticals 608.72 2.52 0.42% 20.24%
Roche Holding 354.80 5.70 1.63% 11.91%
Sanofi 94.89 2.95 3.21% 19.98%
Sangamo BioSciences 5.52 -0.28 -4.83% -61.10%
Sarepta Therapeutics 66.88 -3.36 -4.78% -25.80%
Vertex Pharmaceuticals 228.22 1.63 0.72% -0.79%
Zogenix 25.92 -0.01 -0.04% 35.35%

Indexes Price Day Year
NASDAQ 13353 -189.34 -1.40% 0.12%
US2000 1931 -45.18 -2.29% -8.32%

Sarepta Therapeutics
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. It is developing therapeutic candidates for a range of diseases and disorders, including Duchenne muscular dystrophy (DMD), Limb-girdle muscular dystrophies (LGMDs) and other neuromuscular and central nervous system (CNS) related disorders. Its commercial products, EXONDYS 51 (eteplirsen) Injection, VYONDYS 53 (golodirsen) Injection and AMONDYS 45 (casimersen) Injection is for the treatment of DMD in patients, who have a confirmed mutation of the DMD gene that is amenable to exon 51, exon 53 and exon 45 skipping. It is also developing gene therapy programs for various forms of LGMDs. Its LGMD product candidate, SRP-9003, is designed to transfer a gene that codes for and restores beta-sarcoglycan protein.